JENNY LITTRELL: Open Payments
NPI 1013316025 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 67 payments from 27 companies in 2025. Trend: 2023 $923 · 2024 $1,334 · 2025 $1,368
Food & beverage: $1,325Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $178 |
| AstraZeneca Pharmaceuticals LP | 5 | $168 |
| Celgene Corporation | 10 | $167 |
| PFIZER INC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Janssen Biotech, Inc. | 3 | $54 |
| Daiichi Sankyo Inc. | 2 | $46 |
| BeOne Medicines USA, Inc. | 2 | $42 |
Products named: REBLOZYL, EPKINLY, KEYTRUDA, ENHERTU, IBRANCE, CARVYKTI, BOSULIF, BEVESPI AEROSPHERE.
Industry payments across AZ — which companies pay providers there.
